Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
ID: 343483Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

State Governments

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343483

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-250.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Centers of Biomedical Research Excellence (COBRE) Phase 1 grant, aimed at enhancing biomedical research capacity in eligible institutions through the establishment of thematic, multi-disciplinary centers. This initiative seeks to strengthen the research infrastructure and support junior investigators in competing for independent funding, particularly in states with historically low NIH grant success rates. The program emphasizes collaboration, mentoring, and infrastructure improvements in specific biomedical research areas aligned with institutional priorities. Interested applicants, including state governments and various minority-serving institutions, can apply for grants with an award ceiling of $1.5 million, with applications due by January 30, 2025. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-250.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-22-250-Full-Announcement.html
    PAR-22-250.html
    The Centers of Biomedical Research Excellence (COBRE) Phase 1 funding opportunity by the National Institutes of Health (NIH) aims to enhance biomedical research capacity in IDeA-eligible institutions. This initiative allows for one application per institution and provides grants to establish research centers that support junior investigators in competing for independent funding. The program includes provisions for research support, mentoring, and infrastructure improvements, focusing on specific biomedical research areas aligned with the institution's strategic priorities. Key components of the application include an Administrative Core to manage the center, a minimum of three and up to five Research Projects led by early-stage or new investigators, optional Research Cores for specialized support, and provisions for Alteration and Renovation to improve existing facilities. Overall, the initiative is designed to foster innovative research capabilities, encourage collaboration, and build a sustainable research environment in states historically underserved by NIH funding, promoting scientific advancement and training in biomedical fields.
    Similar Opportunities
    Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)." This grant aims to support the transition of core resources and biomedical research activities at IDeA-eligible organizations into sustainable and independent operations following COBRE Phase 2 funding. The initiative is particularly significant for enhancing research capabilities and fostering inclusivity within research teams, as it requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Grants can provide up to $750,000 in annual direct costs over a five-year project period, with applications due by September 30, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-216.html.
    Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Limited Competition Renewal of the Centers of Biomedical Research Excellence (COBRE) (Phase 2), aimed at enhancing biomedical research capacity at IDeA-eligible institutions. This program focuses on strengthening research infrastructure and developing investigators to secure independent research funding, extending support for an additional five years for established COBRE Phase 1 centers. Eligible institutions must demonstrate past successes under Phase 1, including publications and grant funding, and applications should include a multi-component structure with an Administrative Core and 2-5 Research Projects led by Early Stage or New Investigators. The total funding amount available is up to $1.5 million, with applications due by May 28, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html.
    Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Biomedical Research Facilities (C06 Clinical Trial Not Allowed) grant, aimed at funding the construction or modernization of biomedical research facilities. This initiative seeks to enhance research infrastructure in academic and nonprofit institutions, particularly focusing on Institutions of Emerging Excellence (IEEs), with an emphasis on projects that support core facilities for broad biomedical research collaboration. Eligible applicants can request up to $8 million over five years, with a strong interest in projects that address women's health, emerging research methods, and increasing breeding capacity for specific nonhuman primates. Interested parties should submit their applications by January 27, 2025, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) program, aimed at enhancing the biomedical research capacity in IDeA-eligible states. This grant opportunity supports statewide networks of higher education and research institutions to foster faculty research, mentoring, and student involvement, with a focus on developing institutional infrastructure. The program allows for a maximum annual budget of $2.75 million over five years, requiring each application to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. Interested applicants can find more information and submit proposals by the closing date of May 22, 2025, and should direct inquiries to grantsinfo@nih.gov.
    Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers of Excellence in Genomic Science (CEGS) program, aimed at supporting innovative, interdisciplinary research in genomic science. This program seeks to establish academic centers that will develop transformative genomic approaches to address significant biomedical challenges, with a focus on integrating advanced technological and computational methods. Each award can provide up to $1.5 million per year for a maximum of five years, with potential renewal for an additional five years, and applications are due by June 23, 2025. Eligible applicants include a range of institutions such as higher education entities, nonprofits, and various government organizations, while foreign entities are not eligible. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Research Centers in Minority Institutions (RCMI) Program, aimed at enhancing research capacity in health sciences at institutions dedicated to educating underrepresented students. This initiative seeks to provide cooperative agreement support to eligible institutions that offer doctorate degrees in health-related fields and have a historical commitment to serving minority populations, with a focus on addressing health disparities. The NIH plans to allocate up to $29 million for fiscal year 2025, supporting up to six awards with annual budgets capped at $3.5 million. Interested applicants must submit their proposals by November 19, 2024, and can find additional information and eligibility criteria at the provided link or by contacting NIH Grants Information at grantsinfo@nih.gov.
    STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the STrengthening Research Opportunities for NIH Grants (STRONG) program, which focuses on conducting structured institutional needs assessments and developing action plans for Resource Limited Institutions (RLIs). The initiative aims to enhance the research capacity of RLIs, which serve historically underrepresented populations in biomedical research and have received NIH support of $0 to $25 million annually over the past three fiscal years. This program is crucial for improving competitiveness for NIH funding and fostering research career development in diverse environments. Eligible institutions can apply for a maximum budget of $250,000 annually for a project period of three years, with applications due by September 18, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations" grant, aimed at enhancing the operational capabilities of shared biomedical research facilities. This funding opportunity specifically targets academic and research institutions to purchase modern scientific equipment that will strengthen research-supporting operations in laboratory core facilities and animal research facilities, while excluding requests for scientific research instruments or building infrastructure components. The maximum award amount is set at $350,000, with applications due by September 25, 2024, and the earliest submission date starting August 26, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) to enhance research on substance use, addiction, and HIV through collaborative efforts among investigators. This program aims to integrate diverse new and early career researchers, particularly from underrepresented backgrounds, to develop innovative approaches and interdisciplinary projects that transform the scientific research landscape. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and government entities, with a maximum project period of five years and a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested parties should note that the application deadline is November 17, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.